ImageneBio, Inc. (IMA) News
Track canonical SquawkNews coverage tagged to IMA, ImageneBio, Inc.. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 9 indexed stories across 6 publication days and is ordered by the same first-publication timeline used by LiveCast.
L
Image Resources Secures A$5 Million Cash Advance From LB Group
Image Resources NL ASX:IMA
NEWS | Sep 23, 2026, 01:45 AM UTC
M
ASX suspends Image Resources securities under Listing Rule 17.3
ASX suspended Image Resources securities from quotation under Listing Rule 17.3.
EQUITY | Sep 16, 2026, 01:25 AM UTC
L
IMA: Olevaprubart advances in phase IIb with robust efficacy, safety, and funding into 2028
Olevaprubart, a next-generation OX40-targeting antibody, is in phase IIb trials for atopic dermatitis and alopecia areata, with strong early efficacy and a favorable safety profile. Top-line data is expected in Q4 next y
NEWS | Sep 14, 2026, 08:48 PM UTC
L
IMA: Olevaprubart's phase IIb trial targets high efficacy and safety in atopic dermatitis, with key data due next year
Olevaprubart, a next-generation OX40 antibody, is in phase IIb trials for atopic dermatitis and alopecia areata, aiming for superior efficacy and safety over prior OX40 programs. Top-line phase IIb data is expected in Q4
NEWS | Sep 14, 2026, 08:17 PM UTC
L
Image Resources Nl Requests Trading Halt
Image Resources NL ASX:IMA
NEWS | Sep 14, 2026, 12:09 AM UTC
L
ImageneBio CEO Kristin Yarema to speak at H.C. Wainwright conference
ImageneBio (IMA) said CEO Kristin Yarema will participate in a fireside chat at the H.C. Wainwright 28th Annual Global Investment Conference in New York on Sept. 14.
EQUITY | Sep 08, 2026, 08:37 PM UTC
L
IMA - ImageneBio to Participate in H.C. Wainwright 28th Annual Global Investment Conference in New York
IMA - ImageneBio to Participate in H.C. Wainwright 28th Annual Global Investment Conference in New York
EQUITY | Sep 08, 2026, 08:30 PM UTC
M
ImageneBio (IMA) reports Nasdaq inducement grants under Rule 5635(c)(4)
ImageneBio (IMA) reports inducement grants under Nasdaq Listing Rule 5635(c)(4), per the company disclosure referenced by the alert.
REGULATION | Aug 17, 2026, 08:30 PM UTC
L
IMA - ImageneBio Reports Second Quarter 2026 Financial Results
IMA - ImageneBio Reports Second Quarter 2026 Financial Results
EARNINGS | Aug 05, 2026, 12:00 PM UTC